InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

- Current share price for MVP : $0.405

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$46 Overseas Registration and Partnership Update 28 May 2014 4:48PM $1.210 $0.405 fallen by 66.53%
$46 Trading Update May 2014 28 May 2014 4:03PM $1.210 $0.405 fallen by 66.53%
$46 Half Yearly Report and Accounts H1 FY2014 21 Feb 2014 2:21PM $1.105 $0.405 fallen by 63.35%
$46 Trading Update 9 Dec 2013 12:57PM $1.150 $0.405 fallen by 64.78%
$46 MVP announces FDA Approval 18 Nov 2013 9:50AM $1.425 $0.405 fallen by 71.58%
$46 Chairman's Address to Shareholders 29 Oct 2013 10:19AM $1.350 $0.405 fallen by 70%
$46 MVP Lodges Marketing Authorisation in Europe 15 Oct 2013 9:00AM $1.450 $0.405 fallen by 72.07%
$46 Preliminary Final Report and Full Year Statutory Accounts 23 Aug 2013 2:23PM $1.680 $0.405 fallen by 75.89%
$46 MVP Announcement - Successful Clinical Study Results 13 Aug 2013 12:18PM $1.620 $0.405 fallen by 75%
$46 MVP ASX Announcement 27 Jun 2013 5:10PM $1.310 $0.405 fallen by 69.08%
$46 MVP ASX Announcement - Update 22 May 2013 1:31PM $1.345 $0.405 fallen by 69.89%
$46 Half Yearly Report and Accounts 22 Feb 2013 2:16PM $1.980 $0.405 fallen by 79.55%
$46 MVP ASX Announcement - European Clinical Trial Results 21 Jan 2013 8:27AM $1.910 $0.405 fallen by 78.80%
$46 December Update 27 Dec 2012 3:04PM $1.695 $0.405 fallen by 76.11%
$46 MVP ASX Announcement - Canadian Tender 7 Nov 2012 9:17AM $1.830 $0.405 fallen by 77.87%
$46 MOU 31 Oct 2012 9:53AM $1.830 $0.405 fallen by 77.87%
$46 Preliminary Final Report and Full Year Statutory Accounts 22 Aug 2012 5:13PM $1.150 $0.405 fallen by 64.78%
$46 MVP ASX Release-European Clinical Trial Successful Completio 6 Aug 2012 3:13PM $0.950 $0.405 fallen by 57.37%
$46 MVP ASX Release CSIRO Invests in MVP 5 Jul 2012 11:55AM $0.925 $0.405 fallen by 56.22%
$46 MVP Further Earnings Guidance 22 Jun 2012 10:20AM $0.790 $0.405 fallen by 48.73%
$46 MVP ASX Release Japanese Licence Agreement 23 May 2012 9:21AM $0.770 $0.405 fallen by 47.40%
$46 MVP Further Earnings Guidance 24 Apr 2012 10:22AM $0.700 $0.405 fallen by 42.14%
$46 MVP Half Yearly Report and Accounts H1FY2012 23 Feb 2012 12:59PM n/a $0.405 n/a
$46 MVP ASX Release German Distribution Agreement 17 Feb 2012 9:21AM $0.550 $0.405 fallen by 26.36%
$46 Preliminary Final Report and Full Year Statutory Accounts 26 Aug 2011 4:28PM $0.460 $0.405 fallen by 11.96%

551 - 575 of 613 results

Page 23 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.